600
Participants
Start Date
October 7, 2022
Primary Completion Date
January 31, 2028
Study Completion Date
January 31, 2028
LT3 (liothyronine)
Addition of liothyronine (LT4/LT3 combination therapy) in patients with persistent tiredness on LT4 monotherapy. To investigate whether addition of LT3 is effective in relieving tiredness.
Placebo
Addition of placebo (LT4 monotherapy) in patients with persistent tiredness on LT4 monotherapy.
RECRUITING
Flevoziekenhuis, Almere Stad
RECRUITING
Amsterdam UMC - Location AMC, Amsterdam
NOT_YET_RECRUITING
Gelre ziekenhuizen, Apeldoorn
RECRUITING
Rijnstate, Arnhem
RECRUITING
Amphia ziekenhuis, Breda
RECRUITING
Van Weel-Bethesda Hospital, Dirksland
RECRUITING
Albert Schweitzer Hospital, Dordrecht
NOT_YET_RECRUITING
Treant, Emmen
RECRUITING
Admiraal de Ruyter Hospital, Goes
RECRUITING
University Medical Center Groningen, Groningen
RECRUITING
Saxenburgh MC, Hardenberg
RECRUITING
Radboudumc, Nijmegen
RECRUITING
Erasmus Medical Center, Rotterdam
RECRUITING
Maasstad Hospital, Rotterdam
RECRUITING
Franciscus Gasthuis & Vlietland, Schiedam
RECRUITING
Zuyderland, Sittard
RECRUITING
University Medical Center Utrecht, Utrecht
RECRUITING
Maxima Medical Center, Veldhoven
NOT_YET_RECRUITING
Vie Curie MC, Venlo
Lead Sponsor
Collaborators (1)
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
ACE Pharmaceuticals BV
OTHER
M. Medici
OTHER